The Study Of Andamertinib Plus Anlotinib In Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT07780578 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07780578
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-30
- Primary completion
- 2028-09-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.